bLong Financial
MRNA icon

bLong Financial’s Moderna MRNA Stock Holding History

bLong Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$394K Buy
+2,047
New +$221K 0.23% 47

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

bLong Financial's MRNA Position: Q3 2026 in Review

bLong Financial opened a new position in Moderna (MRNA) in Q3 2026: 2,047 shares worth $394K. The stake represents 0.23% of the portfolio and ranks #47 among its holdings.

633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • bLong Financial held 2,047 shares of Moderna worth $394K as of Q3 2026.
  • Moderna was a new bLong Financial position in Q3 2026.
  • Moderna made up 0.23% of bLong Financial's portfolio in Q3 2026, its #47 holding.
  • 633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on bLong Financial's 13F filing for Q3 2026, filed 29 Oct 2026.